Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$4/mo
Lower than 91% of peersNiche median $9.9/mo
Creators
Joao Ram
No social account linked
Launched
6y ago
2020-09-30 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@captionfy
  • Launched on Show HN (4 pts)Launch

    Captionfy as an Alternative to YouTube Community Captions

    Oct 13, 2020 · 6y agoLaunch page

  • Launched on Product HuntLaunch

    Make Youtube accessible with community captions

    Sep 30, 2020 · 6y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2020-08-26

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

30 Minutes
$4/once
30 Minutes

Trial: None · 1 paid tier ($4) · Observed 2026-11-08 · Pricing page

Entry price $4/mo, Lower than 91% of peers; “Subtitles, Translation & Dubbing” median is $9.9/mo.View pricing benchmark

Pages & changes

Tracked since 2020-09-30

Key pages

Weekly snapshots
www.captionfy.com/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Captionfy cost?
30 Minutes: $4/once. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Captionfy get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Captionfy and what platforms does it support?
Captionfy is catalogued under Subtitles, Translation & Dubbing: Create subtitles for YouTube. Supported platforms: Web.

Related products in this category

Video & Audio / Subtitles, Translation & Dubbing

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.